Differentiation Potential of Pancreatic Fibroblastoid Cells/Stellate Cells: Effects of Peroxisome Proliferator-Activated Receptor Gamma Ligands

por Kruse, M.-L., Hopf-Jensen, S., Timke, C., Agricola, B., Sparmann, G., Schmid, A., Sipos, B., Arlt, A., Schäfer, H.
Publicado 2011

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer...

por Krempien, R, Muenter, MW, Huber, PE, Nill, S, Friess, H, Timke, C, Didinger, B, Buechler, P, Heeger, S, Herfarth, KK, Abdollahi, A, Buchler, MW, Debus, J
Publicado 2005

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)

por Jensen, AD, Münter, MW, Bischoff, H, Haselmann, R, Timke, C, Krempien, R, Sterzing, F, Nill, S, Heeger, S, Hoess, A, Haberkorn, U, Huber, PE, Steins, M, Thomas, M, Debus, J, Herfarth, KK
Publicado 2006